{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:21:50Z","timestamp":1770978110328,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["K01DA038800"],"award-info":[{"award-number":["K01DA038800"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["K23DA043651"],"award-info":[{"award-number":["K23DA043651"]}]},{"name":"National Institute on Drug Abuse of the National Institutes of Health","award":["R01DA037866"],"award-info":[{"award-number":["R01DA037866"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.drugalcdep.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T02:54:35Z","timestamp":1544237675000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005\u20132014"],"prefix":"10.1016","volume":"195","author":[{"given":"Joseph J.","family":"Palamar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin H.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia S.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0005","series-title":"Choosing Wisely: Ten Things Clinicians and Patients Should Question","author":"American Geriatrics Society","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0010","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","article-title":"Adverse effects from counterfeit alprazolam tablets","volume":"176","author":"Arens","year":"2016","journal-title":"JAMA Internal Med."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0015","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0020","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11606-007-0251-z","article-title":"The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs","volume":"22","author":"Buscemi","year":"2007","journal-title":"J. Gen. Internal Med."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0030","series-title":"Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50)","author":"Center for Behavioral Health Statistics and Quality","year":"2015"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0035","series-title":"National Survey on Drug Use and Health: an Overview of Trend Testing Methods and Applications in NSDUH and Other Studies","author":"Center for Behavioral Health Statistics and Quality","year":"2017"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0040","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","article-title":"Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse","volume":"187","author":"Cook","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1532-5415.2005.00571.x","article-title":"Benzodiazepine use and physical disability in community-dwelling older adults","volume":"54","author":"Gray","year":"2006","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamapsychiatry.2014.436","article-title":"Emergency department visits by adults for psychiatric medication adverse events","volume":"71","author":"Hampton","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0055","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/add.13670","article-title":"Demographic trends among older cannabis users in the United States, 2006\u20132013","volume":"112","author":"Han","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0060","series-title":"Applied Survey Data Analysis","author":"Heeringa","year":"2010"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0065","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/archinte.1995.00430160149015","article-title":"Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life","volume":"155","author":"Herings","year":"1995","journal-title":"Arch. Internal Med."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.addbeh.2016.08.027","article-title":"The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence\u2013 an assessment of demographic and substance use trends, United States, 2003\u20132014","volume":"65","author":"Jones","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1176\/appi.ps.201700095","article-title":"Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999\u20132014","volume":"60","author":"Kaufmann","year":"2018","journal-title":"Psychiatry Serv."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1177\/0269881107077355","article-title":"Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials","volume":"21","author":"Martin","year":"2007","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0090","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/sleep\/30.11.1445","article-title":"Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders: an American Academy of Sleep Medicine report","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0095","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1532-5415.2012.04031.x","article-title":"Effect of Medicare Part D benzodiazepine exclusion on psychotropic use in benzodiazepine users","volume":"60","author":"Ong","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.7326\/M15-2175","article-title":"Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians","volume":"165","author":"Qaseem","year":"2016","journal-title":"Ann. Internal Med."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0105","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1517\/14656566.2011.618496","article-title":"Pharmacological treatment of generalized anxiety disorder","volume":"12","author":"Reinhold","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2018.11.015_bib0110","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: united States, 2010-2014","volume":"65","author":"Warner","year":"2016","journal-title":"Vital Stat. Rep."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618308251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618308251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T04:18:29Z","timestamp":1548821909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618308251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":22,"alternative-id":["S0376871618308251"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.11.015","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005\u20132014","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}